News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
473 Results
Type
Article (22)
Company Profile (1)
Press Release (450)
Section
Business (129)
Deals (21)
Drug Development (98)
FDA (9)
Job Trends (6)
News (251)
Policy (24)
Tag
Accelerated approval (1)
Alliances (27)
Approvals (10)
Autoimmune disease (2)
Best Places to Work (3)
Biotechnology (1)
Cancer (13)
CAR-T (3)
Cell therapy (3)
Clinical research (91)
Collaboration (2)
COVID-19 (1)
C-suite (1)
Data (9)
Earnings (39)
Events (87)
FDA (13)
GLP-1 (2)
Healthcare (41)
Immunology and inflammation (2)
Infectious disease (1)
IPO (11)
Job creations (2)
Legal (2)
Lung cancer (9)
Mergers & acquisitions (10)
NextGen: Class of 2026 (10)
Opinion (1)
People (59)
Phase 1 (22)
Phase 2 (46)
Phase 3 (34)
Pipeline (12)
Postmarket research (5)
Preclinical (8)
Real estate (1)
Regulatory (26)
Research institute (1)
Startups (4)
Venture capital (1)
Date
Last 7 days (1)
Last 30 days (4)
Last 365 days (35)
2026 (4)
2025 (35)
2024 (37)
2023 (32)
2022 (52)
2021 (34)
2020 (23)
2019 (12)
2018 (6)
2017 (14)
2016 (10)
2015 (18)
2014 (20)
2013 (40)
2012 (32)
2011 (36)
2010 (21)
Location
Asia (20)
Australia (3)
California (2)
China (1)
Europe (26)
Japan (2)
Maryland (1)
Massachusetts (41)
New Hampshire (4)
New Jersey (9)
Pennsylvania (1)
Southern California (2)
United States (51)
473 Results for "cullinan oncology.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 5, 2026
·
1 min read
Lung cancer
Cullinan, Taiho’s NSCLC Hopeful Shows ‘Strong Activity,’ Clearing Road to FDA
Cullinan Therapeutics and Taiho Oncology’s zipalertinib elicited promising response rates in two mid-stage studies of non-small cell lung cancer patients with typical and uncommon EGFR mutations.
September 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones
January 8, 2026
·
9 min read
Autoimmune disease
Cullinan Bets $700M+ in Back-Heavy China Deal for Autoimmune T Cell Engager
Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put Cullinan in a better position to target autoimmune diseases.
June 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
November 6, 2025
·
10 min read
Press Releases
Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeting
November 10, 2025
·
1 min read
Press Releases
Cullinan Therapeutics to Participate in Upcoming September 2025 Investor Conferences
August 22, 2025
·
1 min read
Press Releases
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
September 15, 2025
·
1 min read
Press Releases
Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049, Novel FLT3xCD3 T Cell Engager, in Oral Presentation at the 67th ASH Meeting
December 9, 2025
·
12 min read
Press Releases
Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
December 2, 2025
·
8 min read
1 of 48
Next
